The Role of CD56 as an Immunophenotypic Marker in the Clinical Course of Multiple Myeloma
Azat Karabekov, Vadim Kemaikin, Zhandos Burkitbayev, Gulnur Zhakhina, Aigerim Sipenova, Inna Berger, Ulbolsyn Orumbayeva, Zhuldyz Iskakova, Rose Ibragimova, Nazym Temir, Gulnur Mamyr, Olga Kolesnikova, Fariza Shokubaeva, Akbota Tursyn, Meiramgul Yussupova, Aidana Shalkarbekova, Ayagul Ainabay, Alexa · 2026
Read The Role of CD56 as an Immunophenotypic Marker in the Clinical Course of Multiple Myeloma by Azat Karabekov, Vadim Kemaikin, Zhandos Burkitbayev, Gulnur Zhakhina, Aigerim Sipenova, Inna Berger, Ulbolsyn Orumbayeva, Zhuldyz Iskakova, Rose Ibragimova, Nazym Temir, Gulnur Mamyr, Olga Kolesnikova, Fariza Shokubaeva, Akbota Tursyn, Meiramgul Yussupova, Aidana Shalkarbekova, Ayagul Ainabay, Alexa (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13164124.txt.
Description
Azat Karabekov and a large team studied whether a surface marker called CD56 helps predict the course of multiple myeloma, in a study published in two thousand twenty-six. The blood cancer grows in the bone marrow, and CD56 sits on the surface of many myeloma cells. The team checked eighty-eight people at diagnosis and tracked their response to first treatment and to stem cell transplant.
About three in four patients had CD56 on their cells. Those without it grew tumors outside the marrow more often and answered first treatment less well. After transplant, patients who had not relapsed had received more stem cells and showed deeper responses. The marker alone did not settle who lived longer. The authors treat CD56 loss as a warning sign for harder disease, best read with other signs.
Catalog record
| CREATOR | Azat Karabekov, Vadim Kemaikin, Zhandos Burkitbayev, Gulnur Zhakhina, Aigerim Sipenova, Inna Berger, Ulbolsyn Orumbayeva, Zhuldyz Iskakova, Rose Ibragimova, Nazym Temir, Gulnur Mamyr, Olga Kolesnikova, Fariza Shokubaeva, Akbota Tursyn, Meiramgul Yussupova, Aidana Shalkarbekova, Ayagul Ainabay, Alexa |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |